XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Net sales $ 11,882 $ 9,770
Cost of sales 10,062 8,230
Research and development expenses 194 179
Selling, general and administrative expenses 366 334
Amortization of intangibles 101 100
Restructuring and asset related charges - net 0 96
Integration and separation costs 0 65
Equity in earnings (losses) of nonconsolidated affiliates 224 (89)
Sundry income (expense) - net 128 (81)
Interest income 8 15
Interest expense and amortization of debt discount 196 215
Income before income taxes 1,323 396
Provision for income taxes 317 138
Net income 1,006 258
Net income attributable to noncontrolling interests 15 19
Net income available for The Dow Chemical Company common stockholder 991 239
The Dow Chemical Company [Domain]    
Net sales 11,882 9,770
Cost of sales 10,061 8,230
Research and development expenses 194 179
Selling, general and administrative expenses 366 334
Amortization of intangibles 101 100
Restructuring and asset related charges - net 0 96
Integration and separation costs 0 65
Equity in earnings (losses) of nonconsolidated affiliates 224 (89)
Sundry income (expense) - net 119 (82)
Interest income 8 16
Interest expense and amortization of debt discount 196 215
Income before income taxes 1,315 396
Provision for income taxes 317 138
Net income 998 258
Net income attributable to noncontrolling interests 15 19
Net income available for The Dow Chemical Company common stockholder $ 983 $ 239